• In May 2026, MicroVision, Inc. reported first quarter 2026 results, with sales rising to US$935,000 from US$589,000 a year earlier, while net loss narrowed to US$25.29 million and basic loss per share improved to US$0.08 from US$0.12.
• This combination of higher sales and a smaller loss suggests incremental progress in MicroVision’s efforts to scale its lidar and perception technology business.
• We'll examine how this early revenue growth and reduced quarterly loss could influence MicroVision's existing investment narrative around future commercialization.

Find 48 companies with promising cash flow potential yet trading below their fair value.

MicroVision Investment Narrative Recap

To own MicroVision, you have to believe lidar and perception software can move from early pilots to meaningful commercial programs across automotive, industrial and defense customers. The latest quarter’s higher sales and narrower loss point to gradual progress, but they do not materially change the near term catalyst of converting RFQs into signed volume contracts, nor the biggest risk that cash burn and limited revenue could force more dilution if commercialization remains slow.

The most relevant recent development alongside these results is Nasdaq’s January 2026 deficiency notice on MicroVision’s share price. While not an immediate delisting threat, it raises the stakes around near term execution: any evidence that 2026 product launches such as MOVIA S and LCAS are gaining commercial traction could help restore confidence, while continued losses without clearer revenue visibility might keep listing compliance and financing options in sharper focus.

Yet against this slow but improving quarter, investors should be aware that MicroVision still has less than one year of cash runway and...

MicroVision's narrative projects $67.9 million revenue and $5.9 million earnings by 2029. This requires 195.3% yearly revenue growth and a $94.3 million earnings increase from $-88.4 million today.

Uncover how MicroVision's forecasts yield a $2.50 fair value, a 301% upside to its current price.

Exploring Other Perspectives

Before this report, the most optimistic analysts were modeling revenue to climb about 203 percent per year to roughly US$73.3 million by 2028, a far more bullish path than the cautious cash burn and dilution risk many worry about; given Q1 sales of just US$935,000, you can see how views on MicroVision’s trajectory can differ sharply and why this new data could eventually reshape both stories.

Explore 8 other fair value estimates on MicroVision - why the stock might be worth just $1.25!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your MicroVision research is our analysis highlighting 5 important warning signs that could impact your investment decision.
• Our free MicroVision research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate MicroVision's overall financial health at a glance.

Want Some Alternatives?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• Uncover the next big thing with 25 elite penny stocks that balance risk and reward.
• We've uncovered the 10 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Rare earth metals are the new gold rush. Find out which 27 stocks are leading the charge.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.